Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.

Saved in:
Bibliographic Details
Title: Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.
Authors: Kosik-Gonzalez C; Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey. Electronic address: ckosikgo@its.jnj.com., Fu DJ; Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey., Chen LN; Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey., Lane R; Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey., Bloch MH; Yale School of Medicine, New Haven, Connecticut., DelBello M; University of Cincinnati College of Medicine, Cincinnati, Ohio., Moreno C; Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain., Drevets WC; Janssen Research & Development, LLC, a Johnson & Johnson company, San Diego, California., Canuso CM; Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey.
Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2026 Jan; Vol. 65 (1), pp. 42-55. Date of Electronic Publication: 2025 Mar 07.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-5418 (Electronic) Linking ISSN: 08908567 NLM ISO Abbreviation: J Am Acad Child Adolesc Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-5418
DOI:10.1016/j.jaac.2025.02.015